DE3683823D1 - 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel. - Google Patents
2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.Info
- Publication number
- DE3683823D1 DE3683823D1 DE8686114749T DE3683823T DE3683823D1 DE 3683823 D1 DE3683823 D1 DE 3683823D1 DE 8686114749 T DE8686114749 T DE 8686114749T DE 3683823 T DE3683823 T DE 3683823T DE 3683823 D1 DE3683823 D1 DE 3683823D1
- Authority
- DE
- Germany
- Prior art keywords
- alkynyladenosine
- active ingredients
- agents containing
- hypertensive agents
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60240137A JPS6299395A (ja) | 1985-10-25 | 1985-10-25 | 2−アルキニルアデノシンおよび抗高血圧剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3683823D1 true DE3683823D1 (de) | 1992-03-19 |
Family
ID=17055048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686114749T Expired - Fee Related DE3683823D1 (de) | 1985-10-25 | 1986-10-23 | 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4956345A (de) |
EP (1) | EP0219876B1 (de) |
JP (1) | JPS6299395A (de) |
KR (1) | KR870003782A (de) |
AT (1) | ATE72448T1 (de) |
CA (1) | CA1282065C (de) |
DE (1) | DE3683823D1 (de) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0137786B1 (ko) * | 1988-11-15 | 1998-05-15 | 하마구찌 미찌오 | 심장 또는 뇌의 허혈성 질환의 치료, 예방제 |
US5283327A (en) * | 1989-06-20 | 1994-02-01 | Yamasa Shoyu Kabushiki Kaisha | Tri-O-acetyl-2-alkynyladenosines |
WO1991009864A1 (en) * | 1990-01-04 | 1991-07-11 | Yamasa Shoyu Kabushiki Kaisha | Drug for treating or preventing ischemic diseases of heart or brain |
GB9014618D0 (en) * | 1990-06-30 | 1990-08-22 | Wellcome Found | Process for the preparation of pyrimidine nucleosides |
US5189027A (en) * | 1990-11-30 | 1993-02-23 | Yamasa Shoyu Kabushiki Kaisha | 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases |
JP2740362B2 (ja) * | 1991-02-12 | 1998-04-15 | ヤマサ醤油株式会社 | 安定な固体状2‐オクチニルアデノシンおよびその製造法 |
IT1254915B (it) * | 1992-04-24 | 1995-10-11 | Gloria Cristalli | Derivati di adenosina ad attivita' a2 agonista |
EP0601322A3 (de) * | 1992-10-27 | 1994-10-12 | Nippon Zoki Pharmaceutical Co | Adenosindeaminaseinhibitor. |
US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
US5817641A (en) * | 1994-07-21 | 1998-10-06 | Thomas Jefferson University | Treatment of enterotoxigenic diarrhea with 2-substituted adenosine derivatives |
US6117878A (en) * | 1998-02-24 | 2000-09-12 | University Of Virginia | 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
JP3619017B2 (ja) | 1998-06-24 | 2005-02-09 | 日本臓器製薬株式会社 | 新規アラビノシルアデニン誘導体 |
US6232297B1 (en) * | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
US7378400B2 (en) * | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
US7427606B2 (en) * | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
AU4343500A (en) | 1999-04-16 | 2000-11-02 | Schering Corporation | Use of azetidinone compounds |
US6322771B1 (en) | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
US6214807B1 (en) | 1999-06-22 | 2001-04-10 | Cv Therapeutics, Inc. | C-pyrazole 2A A receptor agonists |
USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
US6180615B1 (en) * | 1999-06-22 | 2001-01-30 | Cv Therapeutics, Inc. | Propargyl phenyl ether A2A receptor agonists |
AU2001238665A1 (en) | 2000-02-23 | 2001-09-03 | Cv Therapeutics, Inc. | Method of identifying partial agonists of the a2a receptor |
US6670334B2 (en) | 2001-01-05 | 2003-12-30 | University Of Virginia Patent Foundation | Method and compositions for treating the inflammatory response |
JP4514452B2 (ja) * | 2001-10-01 | 2010-07-28 | ユニバーシティ オブ バージニア パテント ファウンデーション | A2aアゴニスト活性を有する2−プロピルアデノシン・アナログおよびその組成物 |
WO2003051881A1 (en) * | 2001-12-17 | 2003-06-26 | Ribapharm Inc. | Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies |
US20050020915A1 (en) * | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
EP1524984A1 (de) * | 2002-07-29 | 2005-04-27 | Cv Therapeutics, Inc. | Bildgebende verfahren zur myorcardperfusion unter verwendung von a2a-rezeptor-agonisten |
US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
US20050033044A1 (en) * | 2003-05-19 | 2005-02-10 | Bristol-Myers Squibb Pharma Company | Methods for preparing 2-alkynyladenosine derivatives |
TWI346109B (en) | 2004-04-30 | 2011-08-01 | Otsuka Pharma Co Ltd | 4-amino-5-cyanopyrimidine derivatives |
US7442687B2 (en) * | 2004-08-02 | 2008-10-28 | The University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
US7576069B2 (en) * | 2004-08-02 | 2009-08-18 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
CN101068825B (zh) | 2004-08-02 | 2013-05-08 | 弗吉尼亚大学专利基金会 | 具有a2a激动剂活性的具有修饰的5'-核糖基团的2-丙炔基腺苷类似物 |
KR20070083714A (ko) * | 2004-10-20 | 2007-08-24 | 씨브이 쎄러퓨틱스, 인코포레이티드 | A2a 아데노신 수용체 작용제의 용도 |
PL1989214T3 (pl) | 2006-02-03 | 2017-07-31 | Gilead Sciences, Inc. | Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów |
US20080027022A1 (en) * | 2006-02-08 | 2008-01-31 | Linden Joel M | Method to treat gastric lesions |
WO2007120972A2 (en) | 2006-02-10 | 2007-10-25 | University Of Virginia Patent Foundation | Method to treat sickle cell disease |
US8188063B2 (en) * | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
WO2008063712A1 (en) * | 2006-06-22 | 2008-05-29 | Cv Therapeutics, Inc. | Use of a2a adenosine receptor agonists in the treatment of ischemia |
US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
WO2008028140A1 (en) * | 2006-09-01 | 2008-03-06 | Cv Therapeutics, Inc. | Methods and compositions for increasing patient tolerability during myocardial imaging methods |
JP2011502101A (ja) * | 2006-09-29 | 2011-01-20 | ギリアード・パロ・アルト・インコーポレイテッド | 肺疾患の病歴を有する患者における心筋画像化法 |
JP2010515081A (ja) * | 2007-01-03 | 2010-05-06 | ギリアード・パロ・アルト・インコーポレイテッド | 心筋灌流画像化 |
US8058259B2 (en) * | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
US20110064671A1 (en) | 2008-03-10 | 2011-03-17 | Cornell University | Modulation of blood brain barrier permeability |
JP2012504147A (ja) * | 2008-09-29 | 2012-02-16 | ギリアード サイエンシーズ, インコーポレイテッド | 多検出器型コンピュータ断層撮影法において使用するための心拍数コントロール薬およびA−2−α受容体作動薬の組み合わせ |
AU2013296420B2 (en) | 2012-08-01 | 2017-12-07 | Lewis And Clark Pharmaceuticals, Inc. | N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists |
US9822141B2 (en) | 2012-08-01 | 2017-11-21 | Lewis And Clark Pharmaceuticals, Inc. | N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists |
-
1985
- 1985-10-25 JP JP60240137A patent/JPS6299395A/ja active Granted
-
1986
- 1986-10-22 CA CA000521169A patent/CA1282065C/en not_active Expired - Fee Related
- 1986-10-23 AT AT86114749T patent/ATE72448T1/de not_active IP Right Cessation
- 1986-10-23 DE DE8686114749T patent/DE3683823D1/de not_active Expired - Fee Related
- 1986-10-23 EP EP86114749A patent/EP0219876B1/de not_active Expired - Lifetime
- 1986-10-24 KR KR1019860008928A patent/KR870003782A/ko not_active Application Discontinuation
-
1988
- 1988-12-12 US US07/282,892 patent/US4956345A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0219876A3 (en) | 1988-04-27 |
KR870003782A (ko) | 1987-05-04 |
JPS6299395A (ja) | 1987-05-08 |
EP0219876A2 (de) | 1987-04-29 |
JPH0133477B2 (de) | 1989-07-13 |
CA1282065C (en) | 1991-03-26 |
EP0219876B1 (de) | 1992-02-05 |
ATE72448T1 (de) | 1992-02-15 |
US4956345A (en) | 1990-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3683823D1 (de) | 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel. | |
KR870700620A (ko) | 신규 약리학적 화합물 | |
MY100343A (en) | Amide derivative and external medicament comprising same | |
NO174296C (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner | |
KR950701911A (ko) | 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient) | |
ES8801217A1 (es) | Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico | |
ES8207169A1 (es) | Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad. | |
MY106231A (en) | Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones. | |
EP0321968A3 (en) | Compounds active on the cardiovascular system | |
MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
JO1589B1 (en) | Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral | |
ES2046641T3 (es) | Composicion antitumoral. | |
ATE69228T1 (de) | Amidabkoemmlinge. | |
IE893956L (en) | Novel compounds | |
ES2054186T3 (es) | Composicion antihepatopatica. | |
DE3682599D1 (de) | 1-oxa-1-dethia-cephalosporinverbindungen und sie enthaltendes antibakterielles mittel. | |
MY106961A (en) | Antiviral tetrahydroimidazo[1,4] benzodiazepines | |
FR2696746B1 (fr) | Dérivés de l'acide benzèneborinique, leur préparation et leur utilisation comme intermédiaires de synthèse. | |
DK601483D0 (da) | Benzhydrylpiperazinderivater | |
IT1216103B (it) | Peptidi ad attivita' farmaceutica. | |
ES2067140T3 (es) | Compuestos fenilester de acido benzoico y composiciones inhibidoras de la elastasa que contienen los mismos. | |
PH23966A (en) | Imidazoquinozoline compounds as agent for treatment of nephritis | |
KR860002498A (ko) | 1,4-디하이드로피리딘 유도체의 약학조성물 | |
TW360630B (en) | A secoaporphine compounds on arrhythmia | |
ES8500620A1 (es) | Procedimiento para la preparacion de derivados e-homo-eburnanos racemicos u opticamente activos y de sus sales de adicion acidas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |